 CARLSBAD, Calif., June 02, 2021 GLOBE NEWSWIRE -- Qualigen Therapeutics, Inc. NASDAQ: QLGN, a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that its CEO and Chairman Michael Poirier will present and participate at the virtual LD Micro Invitational XI Conference, hosted by Sequire Virtual Events, taking place on June 8-10, 2021. 